Recognized as a global leader in hyaluronic acid technology, and for always pioneering what's next, Fidia offers patients much more than pain relief solutions - we offer hope to live better.
The original safe, proven hyaluronic acid treatment for OA knee pain
The industry's only 2-injection hyaluronic acid treatment for OA knee pain
A hyaluronic acid-based gel that delivers long-lasting vaginal hydration
A natural over-the-counter dietary supplement for joint health and mobility
An amniotic injectable that protects, cushions and lubricates for musculoskeletal care
CartiJoint™ FORTE is the First Product in Fidia’s New Dietary Supplement Portfolio; Uniquely formulated with bioactive Bio-Curcumin Curcugreen™
Florham Park, NJ, March 12, 2019 – NuDYN™ is the First Product in Fidia’s New Orthobiologics Portfolio; A Novel Acellular Amnion-Derived Injectable Allograft
Copenhagen, March 18, 2018 – Fidia farmaceutici today announced the positive results from a phase II trial evaluating efficacy and tolerability of Oncofid®P-B, an innovative Paclitaxel-Hyaluronan Bioconjugate targeted to cancer cells, in patients with primary or recurrent Ta G1-G2 papillary bladder cancer.
Diagnosed with OSTEOARTHRITIS (OA) of the knee?
You may be eligible to participate in a clinical trial
Learn More